Search - tctmd.com

Displaying 1 - 20 of 47

Sort: Relevancy | Date

DCB in STEMI Match DES Through 5 Years: REVELATION

News Daily News

DCB in STEMI Match DES Through 5 Years: REVELATION

March 27, 2024

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

No Stents in STEMI? With Careful Selection, Maybe

News Daily News

No Stents in STEMI? With Careful Selection, Maybe

March 21, 2022

With Some Adjustments, Commissural Alignment Possible With TAVI

News Daily News

With Some Adjustments, Commissural Alignment Possible With TAVI

Michael O'Riordan

September 16, 2021

DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2

News Daily News

DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2

August 16, 2021

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

News Daily News CRT 2021

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

Michael O'Riordan

March 17, 2021

Outcomes Worse for STEMI Patients Without Obvious Risk Factors

News Daily News

Outcomes Worse for STEMI Patients Without Obvious Risk Factors

March 12, 2021

Use of Culprit vs Multivessel PCI for STEMI Tracks With Trial Results

News Daily News

Use of Culprit vs Multivessel PCI for STEMI Tracks With Trial Results

November 04, 2020

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

News Daily News

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Michael O'Riordan

July 07, 2020

News Daily News

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

July 04, 2019

SCAI Updates Statement on Intracoronary Diagnostic Tools

News Daily News

SCAI Updates Statement on Intracoronary Diagnostic Tools

July 17, 2018

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

December 26, 2017

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

Benefits of FFR-Guided Complete Revascularization in STEMI May Be Limited to Most Severe Disease

News Daily News

Benefits of FFR-Guided Complete Revascularization in STEMI May Be Limited to Most Severe Disease

April 21, 2017

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

News Daily News

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

Michael O'Riordan

April 18, 2017

Physically Active Less Likely to Die After MI Than Sedentary Individuals

News Daily News

Physically Active Less Likely to Die After MI Than Sedentary Individuals

Michael O'Riordan

April 14, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.